HSPMdb Accession No | HSPMDB002372 |
PMID | 22123255 |
Target | Hsp100 |
HSP Name | ClpP2 |
Organism | Bacteria |
Localization | Cytosol |
Cellular activity | Antibacterial activity |
Compound Name | ADEP3 |
IUPAC Name | 1-(3-cyclohexylpropanoyl)-1-[(3,5-difluorophenyl)methyl]-3-[(3S,9S,13S,15R,19S,22R)-15,19-dimethyl-2,8,12,18,21-pentaoxo-11-oxa-7,17,20-triazatetracyclo[20.4.0.0³,?.0¹³,¹?]hexacosan-9-yl]urea |
SMILES | C[C@@H]1C[C@@H]2N(C1)C(=O)[C@H](C)NC(=O)[C@@H]1CCCCC1C(=O)[C@@H]1CCCN1C(=O)[C@H](COC2=O)NC(=O)N(CC1=CC(F)=CC(F)=C1)C(=O)CCC1CCCCC1 |
Class | Acyldepsipeptide analogue |
Site of Interaction | Nucleotide binding domain |
Cellular assay | Bacterial growth inhibition assay (OD based) |
MIC/MBC | >100 ug/ml (MIC99) |
Cellular Model | S. aureus |
Disease | Bacterial infection |